Tissue microarray for routine clinical breast biomarker analysis. The British Columbia Cancer Agency 2008 experience.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Clinical Pathology

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1309/AJCP1IU7BTSAQGYZPMID 20472849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.

  2009cited by this paper
• Protocol for the examination of specimens from patients with invasive carcinoma of the breast.

  2009cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2007cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Tissue Microarrays: A Powerful Tool for High-Throughput Analysis of Clinical Specimens: A Review of the Method With Validation Data

  2002cited by this paper
• Tissue microarray: a new technology for amplification of tissue resources.

  2001cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper

• Unlocking breast cancer in Brazilian public health system: Using tissue microarray for accurate immunohistochemical evaluation with limitations in subtyping

  2025cites this paper
• Gene Expression Detection Assay for Cancer Clinical Use

  2018cites this paper
• Breast Biomarkers-Comparison on Whole Section and Tissue Microarray Section.

  2017cites this paper
• The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study

  2015cites this paper
• Author's response to reviews Title:Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer and their putative prognostic value Authors:

  2015cites this paper
• Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.

  2013cites this paper
• Cell and Tissue Microarray Technologies for Protein and Nucleic Acid Expression Profiling

  2013cites this paper
• The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.

  2013cites this paper
• Tissue microarray design and construction for scientific, industrial and diagnostic use

  2012cites this paper
• Identification of Common Tumor Signatures Based on Gene Set Enrichment Analysis

  2012cites this paper
• Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study

  2012cites this paper